Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amy Shepherd

Pediatric Emergency Medicine Jackson, MS Medical Doctor

NPI 1881638666 CMS profile 175778

2500 N State St, Jackson, MS 39216

Open in the dashboard

General payments

$3,697

212 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amy Shepherd of Jackson, MS is reported in the CMS Open Payments database as having received $3,697 across 212 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pediatric Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $502 25
2024 General $628 31
2023 General $586 28
2022 General $503 32
2021 General $438 27
2020 General $464 30
2019 General $575 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amy Shepherd
  • Pediatric Emergency Medicine median
  • Middle half of Pediatric Emergency Medicine
  • National median

In program year 2025, general payments to Amy Shepherd were reported at $502. Among 239 Pediatric Emergency Medicine profiles paid that year, the median was $53 and the middle half received between $24 and $126.

Show as a table
Year Amy Shepherd Pediatric Emergency Medicine median Middle half National median
2019 $575 $65 $22–$126 $163
2020 $464 $25 $18–$99 $114
2021 $438 $45 $24–$128 $132
2022 $503 $77 $23–$150 $149
2023 $586 $52 $22–$127 $160
2024 $628 $63 $22–$143 $164
2025 $502 $53 $24–$126 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $720 41 payments
  2. Ironshore Pharmaceuticals Inc. $629 31 payments
  3. Corium, Inc. $425 21 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $339 27 payments
  5. Merck Sharp & Dohme Corporation $309 16 payments
  6. Supernus Pharmaceuticals, Inc. $256 18 payments
  7. Sanofi Pasteur Inc. $205 9 payments
  8. Collegium Pharmaceutical, Inc. $177 9 payments
  9. GlaxoSmithKline, LLC. $133 9 payments
  10. Pfizer Inc. $125 8 payments
  11. Other $379 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,690 211 payments
  2. Education $7 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $425 21 payments
  2. JORNAY PM Central Nervous System Stimulant $387 20 payments
  3. VYVANSE $296 18 payments
  4. Dyanavel XR $260 14 payments
  5. VAXNEUVANCE $225 10 payments
  6. GARDASIL 9 $208 13 payments
  7. VAXELIS Vaccine $181 11 payments
  8. Jornay PM Adhd $177 9 payments
  9. QELBREE $171 14 payments
  10. VAXELIS Vaccines $151 6 payments
  11. Other $2,244 133 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

212 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Emergency Medicine in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record